-+ 0.00%
-+ 0.00%
-+ 0.00%

Merck KGaA to Develop AI-driven Support Model for Rare Tumors in Partnership with Nvidia, Microsoft, Dawn Health

MT Newswires·10/21/2026 10:19:48
Listen to the news
10:19 AM EDT, 10/21/2026 (MT Newswires) -- Merck KGaA (MRK.F), Nvidia (NVD.F), Microsoft (MSF.F) and Denmark-based Dawn Health will explore the use of artificial intelligence in customizing support programs for patients with rare tumors under their latest collaboration. The German science and technology company will work on the design of the new model, Nvidia will leverage its AI technology and services, Microsoft will provide its cloud platform, and Dawn Health will lead product and application development, as well as regulatory processes, according to a Wednesday release. The model will initially focus on desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas, with primary rollout planned across key markets in Europe.